US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 484.740
  • -0.080-0.02%
Close Apr 1 16:00 ET
  • 484.750
  • +0.010+0.00%
Post 18:35 ET
124.48BMarket Cap-233.05P/E (TTM)

Vertex Pharmaceuticals Key Stats

Vertex Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
2.78B
2.91B
+131.28M
Beat Est.
+10.45%
+15.66%
+4.72%
EPS
3.66
3.50
-0.16
Miss Est.
-1.45%
-5.66%
-4.27%
Buy

Apr 1, 2025

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 23 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.914B--
--2025/Q1-- / 2.853B--
Feb 10, 20252024/Q42.912B / 2.781B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.914B--
--2025/Q1-- / 2.853B--
Feb 10, 20252024/Q42.912B / 2.781B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More